The Interplay Between FDA Approval And Discovery Rule

Law360, New York (March 08, 2012, 1:26 PM ET) -- Adopting a middle-of-the-road approach that may raise more questions than it answers, the New Jersey Supreme Court has ruled that U.S. Food and Drug Administration (FDA) approval of drug and medical device warnings creates a presumption against application of the discovery rule to a defendant’s otherwise-valid statute of limitations defense.

New Jersey’s Product Liability Act (PLA) creates a rebuttable presumption that warnings or instructions approved by the FDA are adequate. Indeed, in discussing the impact of this presumption on the merits of a plaintiff’s failure-to-warn claim,...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers